NIH clears a kratom compound for its first human safety test in opioid use disorder
The National Institutes of Health has opened a long-awaited clinical question: can a purified compound from kratom be studied safely in people as a possible treatment for opioid use disorder? NIH announced on June 1, 2026, that its Investigational New Drug application for mitragynine has taken effect with the U.S. Food and Drug Administration. The…








